Trademark: 86753502
Word
SEQ LL
Status Date
Monday, January 9, 2017
Filing Date
Thursday, September 10, 2015
Published for Opposition
Tuesday, April 12, 2016
Abandoned Date
Monday, January 9, 2017
1 Diagnostic tests and test kits, chips, arrays, and analyzers for conducting single molecule sequencing reactions, namely, reactions for the sequencing of DNA and/or RNA for genomic analysis for scientific and research purposes; diagnostic tests and test kits, chips, arrays, and analyzers for determination of genomic information by sequencing for scientific and research purposes; Assays and reagents for use in genetic research; Test kits for conducting RNA and DNA sequencing for laboratory or research use; Diagnostic tests and test kits, chips, arrays, and analyzers for conducting single molecule sequencing reactions, namely, reactions for the sequencing of DNA and/or RNA for genomic analysis for clinical or medical laboratory purposes; diagnostic tests and test kits, chips, arrays, and analyzers for determination of genomic information by sequencing for clinical or medical laboratory purposes
5 Preparations for detecting genetic predispositions for medical purposes; Medical diagnostic reagents and assays that test for detection of genetic traits, genetic degeneration, genetic diseases and genetic abnormalities
9 Computer software and hardware, namely, optical detection machines, for use in DNA and RNA sequencing for genomic analysis and for determination of genomic information by sequencing; Computer software for scientific analysis of genetic sequences; Laboratory devices for detecting genetic sequences; Diagnostic apparatus for the detection of genetic traits, genetic degeneration, genetic diseases and genetic abnormalities for laboratory or research use
10 Medical testing devices for DNA and RNA sequencing
42 Product research and development services for others in the field of genomics; medical and scientific research and development services in the field of genomics; Genetic testing for scientific research purposes; Genetic mapping for scientific purposes; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics
44 Genetic testing for medical purposes; Pre-natal testing services; Medical testing for diagnostic or treatment purposes; Genetic testing for medical purposes
Color is not claimed as a feature of the mark.
The mark consists of the letters "SEQ" and the letters "LL" with a stylized double helix ladder design between the aforementioned lettering.
SEQUEL
Jan 9, 2017
Abandonment Notice Mailed - No Use Statement Filed
Jan 9, 2017
Abandonment - No Use Statement Filed
Jun 7, 2016
Noa E-Mailed - Sou Required From Applicant
Apr 12, 2016
Official Gazette Publication Confirmation E-Mailed
Apr 12, 2016
Published For Opposition
Mar 23, 2016
Notification Of Notice Of Publication E-Mailed
Mar 10, 2016
Law Office Publication Review Completed
Mar 7, 2016
Approved For Pub - Principal Register
Mar 7, 2016
Examiner's Amendment Entered
Mar 7, 2016
Notification Of Examiners Amendment E-Mailed
Mar 7, 2016
Examiners Amendment E-Mailed
Mar 7, 2016
Examiners Amendment -Written
Feb 9, 2016
Previous Allowance Count Withdrawn
Feb 2, 2016
Withdrawn From Pub - Og Review Query
Jan 21, 2016
Law Office Publication Review Completed
Jan 14, 2016
Approved For Pub - Principal Register
Jan 14, 2016
Teas/Email Correspondence Entered
Jan 14, 2016
Correspondence Received In Law Office
Jan 14, 2016
Assigned To Lie
Dec 28, 2015
Teas Response To Office Action Received
Dec 28, 2015
Notification Of Non-Final Action E-Mailed
Dec 28, 2015
Non-Final Action E-Mailed
Dec 28, 2015
Non-Final Action Written
Dec 22, 2015
Assigned To Examiner
Sep 17, 2015
Notice Of Design Search Code And Pseudo Mark E-Mailed
Sep 16, 2015
New Application Office Supplied Data Entered In Tram
Sep 14, 2015
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
